Discover
ACAD
ACADIA Pharmaceuticals Inc.
27.29
1 x 23.32
1 x 31.30
bid
ask
-
0.16
0.58%
1 @ 04:09 AM
27.20 -0.09 (0.33%)
| Ytd | 2.17% | |
| 1y | 10.22% |
26.74
day range
27.48
19.69
52 week range
30.96
| Open | 27.37 | Prev Close | 27.45 | Low | 26.74 | High | 27.48 | Mkt Cap | 4.67B |
| Vol | 5.48M | Avg Vol | 1.71M | EPS | 2.23 | P/E | 12.24 | Forward P/E | 30.66 |
| Beta | 0.86 | Short Ratio | 5.57 | Inst. Own | 99.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 27.61 | 200-d Avg | 24.62 | 1yr Est | 33.89 |
ACAD News
benzinga.com
Acadia Pharmaceuticals Receives Preliminary Court Approval Of Settlement Of Kanner Et Al. V. Biggar
On August 24, 2026, the United States District Court for the Southern District of California (the &#
benzinga.com
Deutsche Bank Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $38
Deutsche Bank analyst David Hoang maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Buy and r
benzinga.com
Morgan Stanley Maintains Equal-Weight on ACADIA Pharmaceuticals, Raises Price Target to $28
Morgan Stanley analyst Jeffrey Hung maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Equal-W
benzinga.com
Citigroup Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $40
Citigroup analyst Yigal Nochomovitz maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Buy and